Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
AstraZeneca
(https://www.astrazeneca.com) 📸 Data Snapshot: May 16, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE AstraZeneca – Research-Based BioPharmaceutical Company (https://www.astrazeneca.com)
AstraZeneca – Research-Based BioPharmaceutical Company
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
NAV_HEADING_REPEATED_BODY (https://astrazeneca.com/media-centre/articles.html)
NAV_HEADING_REPEATED_BODY_FOOTER (https://astrazeneca.com/sustainability.html)
NAV_HEADING_REPEATED_BODY_FOOTER (https://astrazeneca.com/media-centre.html)
NAV_HEADING_REPEATED_FOOTER (https://astrazeneca.com/investor-relations.html)
NAV_HEADING_REPEATED_FOOTER (https://astrazeneca.com/partnering.html)
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://www.astrazeneca.com) AstraZeneca – Research-Based BioPharmaceutical Company
[H2] Trending story Advancing Science in Uncontrolled Hypertension Disease understanding [H2] Featured articles Obesity and weight management: Transforming care through science Articles Transforming cardiovascular care and the burden of heart failure Articles Keep up to date with the latest news At AstraZeneca, we are taking concerted action to improve the health of people, society, and the planet. We believe our greatest impact comes when we match our ambition to transform patient outcomes through innovative science with bold action on climate and nature, health equity, and health systems resilience. Pam Cheng, EVP, Global Operations, IT and Chief Sustainability Officer, AstraZeneca Our Sustainability Impact Discover how we champion inclusion and diversity at AstraZeneca We have 186 projects in our pipeline View pipeline Learn about our cell therapy ambition The Discovery Centre in Cambridge (UK) is one of our global science centres Explore all our science centres [H2] Sustainability at AstraZeneca Explore our Media Centre for more news
SUB-PAGE · THIN (https://astrazeneca.com/media-centre/articles.html)
SUB-PAGE · THIN (https://astrazeneca.com/sustainability.html)
SUB-PAGE · THIN (https://astrazeneca.com/media-centre.html)
SUB-PAGE · THIN (https://astrazeneca.com/investor-relations.html)
SUB-PAGE · THIN (https://astrazeneca.com/partnering.html)
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 2 | 1 |
| /media-centre/articles.html | 0 | 0 |
| /sustainability.html | 0 | 0 |
| /media-centre.html | 0 | 0 |
| /investor-relations.html | 0 | 0 |
| /partnering.html | 0 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage schema
{
"@context": "http://schema.org",
"@type": "WebSite",
"url": "https://www.astrazeneca.com/content/astraz.html",
"name": "AstraZeneca",
"alternateName": "AstraZeneca",
"potentialAction": {
"@type": "SearchAction",
"target": "https://www.astrazeneca.com/content/astraz/search-results.s.html?q={search_term_string}",
"query-input": "required name=search_term_string"
}
}
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
AstraZeneca has 0.3 points more BS than the average for Medical Devices, Pharma & Biotech.
Medical Devices, Pharma & Biotech BS: AstraZeneca (www.astrazeneca.com)
AstraZeneca operates behind a high-gloss corporate curtain where generic ‘innovation’ jargon masks the hard data of its pipeline. The site scores as Moderate BS because while it is a legitimate entity, its digital presence prioritizes brand theater over the granular clinical proof expected in the biotech sector. The high level of template language and vague headings creates a significant signal-to-substance gap.
Immediately replace the H1 ‘What science can do’ with a factual authority claim, such as ‘Leading 186 Active Clinical Trials in Oncology and Cardiovascular Science.’ Implement MedicalOrganization schema with SameAs links to ClinicalTrials.gov and official regulatory filings for every mentioned therapeutic area. Populate the ‘Media Centre’ and ‘Sustainability’ pages with specific, crawlable PDF or HTML summaries of peer-reviewed results to eliminate the ‘insufficient’ data flags. Add specific ISO or GMP certification details to the footer to ground the ‘global science centre’ claims in regulatory reality.
The content perfectly aligns with the Pharma & Biotech industry, specifically referencing therapeutic areas like hypertension, obesity, and cardiovascular care. The mention of a ‘pipeline’ with ‘186 projects’ is a definitive industry-specific technical signal.
“The score of 41 is primarily driven by the high cliché density (11/15) and the lack of information density in headings and sub-pages (14/30). While the company's real-world authority is high, the forensic crawl proves that its digital substance is often deferred to external or unlinked reports, leaving the web presence in the 'Moderate BS' range. The trust theatre score is elevated by the presence of unverified review metadata.”
This training module utilizes a snapshot of public data from AstraZeneca, captured on May 16, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to AstraZeneca: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://www.astrazeneca.com to view the most current version of its content and learn from the source what this company is about and what it offers.